• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

nuvaira

Nuvaira gains FDA breakthrough nod for lung denervation system

June 8, 2020 By Nancy Crotti

Obstructive lung disease treatment developer Nuvaira said today that the FDA has designated its lung denervation system a breakthrough device. The Nuvaira lung denervation system enables a novel bronchoscopic procedure that disrupts pulmonary nerve input to the lung to reduce the clinical consequences of neural hyperactivity, which causes airway hyper-responsiveness or “lung attacks” in both COPD […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Respiratory Tagged With: Centers for Medicare and Medicaid Services (CMS), COVID-19, FDA, nuvaira

Nuvaira announces Griffin as new CFO

February 5, 2020 By Sean Whooley

Obstructive lung disease treatment developer Nuvaira announced that Tom Griffin joined the company as its new chief financial officer. Griffin has a 30-year record of leadership roles that included guiding companies through investment financing, commercialization growth and IPO stages, according to a news release. He most recently served as CFO at Avedro, which completed its […]

Filed Under: Business/Financial News, Clinical Trials, Respiratory Tagged With: nuvaira, Personnel Moves

Nuvaira touts dNerva lung denervation studies

August 21, 2019 By Sean Whooley

Nuvaira announced multiple peer-reviewed studies that provide further evidence of safety, clinical effectiveness and the mechanisms of targeted lung denervation. The Plymouth, Minn.-based company’s dNerva system is a bronchoscopic procedure designed to disrupt pulmonary nerve input to the lung, reducing the consequences of neural hyperactivity in chronic obstructive pulmonary disease. Nuvaira’s IPS-II trial showed successful […]

Filed Under: Clinical Trials, Endoscopic, Respiratory Tagged With: nuvaira

Medical Alley companies beat Q1 investment total

April 1, 2019 By Nancy Crotti

A surge in first-quarter 2019 investments in Medical Alley Association member startups pushed them past their performance in the same quarter last year, according to the Minnesota-based trade group. Seven of the 10 largest raises of the quarter went to medical device companies, which propelled the sector to its best first quarter on record, nearly doubling the […]

Filed Under: Business/Financial News, Funding Roundup, News Well Tagged With: CHF Solutions Inc., Medical Alley Assn., Monteris Medical, nuvaira

Nuvaira raises $79m to support COPD device

February 11, 2019 By Fink Densford

Respiratory device developer Nuvaira said today that it raised $79 million in a new equity financing round to support its Lung Denervation System. The Lung Denervation System is intended to treat airway hyper-responsiveness, which the Minneapolis-based company said is a pathophysiologic underpinning of both chronic obstructive pulmonary disease and asthma, through a procedure called Targeted […]

Filed Under: Business/Financial News, Featured, Respiratory, Wall Street Beat Tagged With: nuvaira

5 medtech funding insights you need to know

July 7, 2017 By Heather Thompson

Venture capital funding isn’t what it used to be for medical device startups, but there are actually reasons to feel optimistic about medtech funding. That was the big takeaway from a four-expert panel at DeviceTalks Minnesota last month. (The next DeviceTalks is Oct. 2 in Boston.) Charlie Whelan, director of transformational health consulting at Frost & Sullivan, […]

Filed Under: Business/Financial News, Funding Roundup Tagged With: Baxter, baxterventures, DeviceTalks, FDA, Frost & Sullivan, funding, nuvaira, thomasmcnerneypartners, venture capital

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy